Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tereza Gabelić

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
International Journal of Dermatology|June 28, 2024
Lupus-like local skin reaction to subcutaneously administered interferon-β in a patient with multiple sclerosisLucija Tomić, Tereza Gabelić, Mirna Bradamante
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|May 17, 2011
Central positioning upbeat nystagmus and vertigo due to pontine strokeMario Habek, Tereza Gabelić, Goran Pavliša, et al.
Acta Neurologica Belgica|June 7, 2012
Treatment of facial myokymia in multiple sclerosis with botulinum toxinMario Habek, Ivan Adamec, Tereza Gabelić, et al.
Clinical Neurology and Neurosurgery|December 11, 2013
Delay in the diagnosis of multiple sclerosis in CroatiaIvan Adamec, Barbara Barun, Tereza Gabelić, et al.
Acta Neurologica Belgica|November 12, 2009
Giant arachnoidal cystTereza Gabelić, Natasa Klepac, Zdenko Mubrin, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|March 23, 2026
Saccadic Pulses as a Major Sign of Internuclear Ophthalmoplegia in Multiple SclerosisKatarina Tešija, Luka Crnošija, Mašan Sredanović, et al.
Clinical EEG and Neuroscience|March 29, 2013
Tongue somatosensory-evoked potentials: evaluation of the afferent trigeminal pathway in patients with early multiple sclerosisTereza Gabelić, Magdalena Krbot Skorić, Ivan Adamec, et al.
Human Vaccines & Immunotherapeutics|October 20, 2021
Product review on MAbs (alemtuzumab and ocrelizumab) for the treatment of multiple sclerosisTereza Gabelić, Barbara Barun, Ivan Adamec, et al.
Journal of Neurology|September 20, 2025
Diagnostic performance of the 2010, 2017, and 2024 McDonald criteria: clinical implications in multiple sclerosisMario Habek, Ivan Adamec, Tereza Gabelić, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 3, 2011
Primary position upbeat nystagmusIvan Adamec, Tereza Gabelić, Magdalena Krbot, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
International Journal of Dermatology|June 28, 2024
Lupus-like local skin reaction to subcutaneously administered interferon-β in a patient with multiple sclerosisLucija Tomić, Tereza Gabelić, Mirna Bradamante
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|May 17, 2011
Central positioning upbeat nystagmus and vertigo due to pontine strokeMario Habek, Tereza Gabelić, Goran Pavliša, et al.
Acta Neurologica Belgica|June 7, 2012
Treatment of facial myokymia in multiple sclerosis with botulinum toxinMario Habek, Ivan Adamec, Tereza Gabelić, et al.
Clinical Neurology and Neurosurgery|December 11, 2013
Delay in the diagnosis of multiple sclerosis in CroatiaIvan Adamec, Barbara Barun, Tereza Gabelić, et al.
Acta Neurologica Belgica|November 12, 2009
Giant arachnoidal cystTereza Gabelić, Natasa Klepac, Zdenko Mubrin, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|March 23, 2026
Saccadic Pulses as a Major Sign of Internuclear Ophthalmoplegia in Multiple SclerosisKatarina Tešija, Luka Crnošija, Mašan Sredanović, et al.
Clinical EEG and Neuroscience|March 29, 2013
Tongue somatosensory-evoked potentials: evaluation of the afferent trigeminal pathway in patients with early multiple sclerosisTereza Gabelić, Magdalena Krbot Skorić, Ivan Adamec, et al.
Human Vaccines & Immunotherapeutics|October 20, 2021
Product review on MAbs (alemtuzumab and ocrelizumab) for the treatment of multiple sclerosisTereza Gabelić, Barbara Barun, Ivan Adamec, et al.
Journal of Neurology|September 20, 2025
Diagnostic performance of the 2010, 2017, and 2024 McDonald criteria: clinical implications in multiple sclerosisMario Habek, Ivan Adamec, Tereza Gabelić, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 3, 2011
Primary position upbeat nystagmusIvan Adamec, Tereza Gabelić, Magdalena Krbot, et al.
Pageof 6